Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Science and Technology Daily: a experiência da China contra a COVID-19 pode ajudar o mundo a lutar contra a epidemia
  • Latin America - español
  • USA - Nederlands
  • USA - Deutsch
  • USA - Français
  • USA - English


News provided by

Science and Technology Daily

Mar 26, 2020, 19:51 ET

Share this article

Share toX

Share this article

Share toX

PEQUIM, 26 de março de 2020 /PRNewswire/ -- O jornal Science and Technology Daily anuncia:

Apesar de a epidemia de COVID-19 continuar na Europa, a China já obteve a vitória programada através de um método científico no combate contra o vírus da COVID-19. De acordo com os últimos dados oficiais, a situação da infecção na China foi controlada inicialmente e apenas poucos casos, ou até mesmo nenhum, foram relatados durante os vários últimos dias. Enquanto isso, pesquisadores chineses começaram a compartilhar a experiência "Anti-COVID-19" da China a pedido de vários países.  

Um encontro médico global on-line foi realizado em Pequim às 20h do dia 19 de março visando compartilhar a experiência da China na prevenção e contenção da COVID-19, a doença causada pelo novo coronavírus. Muitos acadêmicos chineses como Zhong Nanshan, Li Lanjuan e Qiao Jie participaram do encontro que constou de discussões com colegas de outros países. Responderam a mais de dez perguntas de especialistas internacionais e usuários on-line, e cerca de 70.000 profissionais médicos e cidadãos da internet ao redor do mundo assistiram à reunião virtual.

O "Método Wuhan" está se tornando um dos métodos mais representativos da luta contra a epidemia. A situação provou o que Dr. Tedros Adhanom Ghebreyesus, secretário-geral, disse anteriormente, isto é, a epidemia ocorrida na China está sob controle até agora, e as ações do país contra a COVID-19 têm também apresentado um sucesso comprovado. Em outras palavras, a implementação do "Método Wuhan" desempenha um papel crucial no sucesso da China no combate à epidemia.

O "Método Wuhan" inclui especificamente três orientações importantes.

Primeiro, uma "estratégia de fechamento" foi realizada em Wuhan pelo governo chinês para a redução do fluxo de pessoas, indicando que todos os locais públicos, como bares, cinemas, faculdades, foram fechados durante o combate contra a Covid-19. Simultaneamente, o governo chinês monitorou ativamente as condições de saúde pública não apenas em Wuhan, mas também em outras cidades e implementou a política central de "monitoramento proativo, detecção precoce, diagnóstico, isolamento e tratamento, e isolamento e rastreamento severo de contatos próximos de pacientes da COVID-19".

Segundo, para interromper a fonte de infecção, prevenir a propagação da epidemia em larga escala e aliviar a carga do sistema médico local em Wuhan, a China transformou grandes prédios públicos, como estádios, em vários hospitais especiais com o objetivo de reduzir a pressão do sistema médico local. O hospital especial denomina-se "hospital improvisado", um tipo de sistema médico de campo móvel do Exército de Libertação Popular (People's Liberation Army – PLA), no qual incluem-se unidades diferentes, entre elas a unidade de tratamento médico, de enfermaria e de suporte técnico. Com a construção dos hospitais, garantiu-se o tratamento de emergência, cirúrgico, testes clínicos e outros tratamentos médicos para pacientes da COVID-19.

Terceiro, o povo chinês colaborou ativamente com o governo. Inúmeras equipes médicas de várias províncias dirigiram-se rapidamente para Wuhan para ajudar a diagnosticar e tratar os pacientes da COVID-19 no local, enquanto as pessoas não infectadas ficaram em quarentena para evitar o contato próximo com os patógenos.

Até o momento, vários países europeus têm aprendido com o "Método Wuhan".

No dia 16 de março, o presidente francês Emmanuel Macron declarou nos canais da televisão nacional a adoção de medidas severas que "nunca tinham sido implementadas em tempos de paz" contra a COVID-19, incluindo a restrição de viagens públicas por, no mínimo 15 dias; o adiamento do segundo turno das eleições municipais; a interrupção de reformas governamentais em andamento; a expropriação de taxis e hotéis pelo estado; e também a responsabilidade do exército francês pela transferência de pacientes e pela implementação de hospitais de campo nas áreas seriamente atingidas. Em resumo, a França, após a Itália e a Espanha, tornou-se o terceiro país europeu a impor a lei marcial.

A França está gradualmente promovendo várias medidas ao implementar finalmente o "Método Wuhan", indicando que a experiência antiepidêmica da China foi colocada em prática. Dominique BERTRAND, presidente da Comissão Nacional de Saúde Pública, acredita que as medidas de quarentena da China foram altamente eficazes e provocaram resultados favoráveis representando uma referência importante para a França. O país não impôs a lei marcial imediatamente para proporcionar ao público um período de adaptação à situação, em consideração às características nacionais da França, o que torna difícil a obtenção do sucesso em um passo completo.

A disseminação do vírus está sempre à frente dos números confirmados. A Organização Mundial de Saúde declarou novamente: "O tempo que a China obteve para o mundo está se esgotando".

BERTRAND enfatizou que a colaboração internacional no surto atual de COVID-19 é necessária, apoiando e esperando que a China organize a cooperação internacional para a situação. Atualmente, vários países precisam entender porque a China está tomando essas medidas e, em particular, a eficácia das mesmas. A França espera fortalecer a cooperação com a China, que superou o teste com sucesso, na luta contra a epidemia. Resumidamente, a França atribui uma grande importância à experiência da China em face da epidemia.

FONTE Science and Technology Daily

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Also from this source

Cooperation Call at NEV Congress to Boost Green Transformation

Cooperation Call at NEV Congress to Boost Green Transformation

"I firmly believe that the number of new energy vehicles (NEVs) will continue to rise very dynamically in China, but also in other regions of the...

Science and Technology Daily: Xi'an, Where Ancient Culture Meets Smart Future

Science and Technology Daily: Xi'an, Where Ancient Culture Meets Smart Future

Xi'an in northwest China, where the ancient Silk Road began, now symbolizes China's fusion of heritage and innovation. Part of our "Into Tech Park"...

More Releases From This Source

Explore

Infection Control

Infection Control

Health Care & Hospitals

Health Care & Hospitals

Publishing & Information Services

Publishing & Information Services

News Releases in Similar Topics

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.